Halo Pharma - About the company
Halo Pharma is an acquired company based in Hanover (United States), founded in 2006. It operates as a CDMO offering integrated drug development services. Halo Pharma has raised $25M in funding. The company has 879 active competitors, including 28 funded and 135 that have exited. Its top competitors include companies like Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals.
Company Details
Halo Pharmaceutical is a contract development and manufacturing organization which specializes in pediatric dosage forms. Services offered include pharmaceutical development, commercial manufacturing, analytical services for APIs and testing services. Pharmaceutical development services offered include project management, formulation development and analytical development. It has acquired manufacturing facilities from companies like Abbott and Teva to meet the commercial manufacturing needs of its clients by supplying solids, liquids, sterile ointment and packaging services. It also offers chemical and analytical services for pharmaceutical key intermediates and API – from development to small-scale commercial production. Testing services offered include chemical and microbiological testing of a complete range of dosage form. Recently, it entered into agreement with Exx pharma to Collaborate on the Development/Manufacturing of Products using Twin Screw Extrusion Technology.
Key Metrics
Founded Year
2006
Location
Hanover, United States
Stage
Acquired
Total Funding
$25M in 2 rounds
Latest Funding Round
Investors
Ranked
9th among 879 active competitors
Employee Count
4 as on Jul 31, 2026
Similar Companies
Exit Details
Acquired by Cambrex (Jul 23, 2018)
Halo Pharma's acquisition details
Click here to take a look at Halo Pharma's acquisition in detail
Sign up to download Halo Pharma's company profile
Halo Pharma's funding and investors
Halo Pharma has raised a total funding of $25M over 2 rounds. Its first funding round was on Jan 06, 2015. Halo Pharma has 2 institutional investors.
Here is the list of recent funding rounds of Halo Pharma:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 10, 2025 | 3110362 | Series B | 8482981 | 3392160 | 7849615 | 5096821 |
Jan 06, 2015 | 5201138 | PE | 7502057 | 9220627 | 6071338 |
View details of Halo Pharma's funding rounds and investors
Halo Pharma's founders and board of directors
Founder? Claim ProfileHalo Pharma's employee count trend
Halo Pharma has 4 employees as of Jul 26. Here is Halo Pharma's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Halo Pharma's Competitors and alternates
Top competitors of Halo Pharma include Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals. Here is the list of Top 10 competitors of Halo Pharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Jubilant Life Sciences 1978, Noida (India), Public | Company offering a suite of R&D and manufacturing services for small molecules and generics | - | 59/100 | |
2nd | CDMO focusing on spectrum of dosage forms and therapeutic segments | $70M | 58/100 | ||
3rd | Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired | Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution | $31M | 57/100 | |
4th | Contract services for pharmaceutical development and manufacturing | - | 54/100 | ||
5th | Contract laboratory and contract manufacturing services for pharmaceutical and animal health industries | - | - | 54/100 | |
6th | Chugai Pharmaceutical 1925, Tokyo (Japan), Acquired | Developer of innovative pharmaceutical products and services | - | 54/100 | |
7th | Asahi Kasei 1931, Chiyoda-ku (Japan), Public | CDMO focused on manufacturing of liquid, solid & injectable drug formulations | - | 53/100 | |
8th | Pontika Aerotech 2017, Paonta Sahib (India), Series A | Contract manufacturer of formulations | $11.9M | 52/100 | |
9th | Halo Pharma 2006, Hanover (United States), Acquired | CDMO offering integrated drug development services | $25M | 52/100 | |
10th | Developer of proprietary stabilizing and protecting solutions for biologics formulation | $17.5M | 52/100 |
Looking for more details on Halo Pharma's competitors? Click here to see the top ones
Halo Pharma's Investments and acquisitions
Halo Pharma has made no investments or acquisitions yet.
Reports related to Halo Pharma
Here is the latest report on Halo Pharma's sector:
News related to Halo Pharma
Media has covered Halo Pharma for a total of 2 events in the last 1 year, 2 of them have been about company updates.
•
•
Halo Pharma Expands New Jersey Plant with High‑Capacity Roller CompactorContract Pharma•Dec 17, 2025•Halo Pharma
•
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable ManufacturingBusiness Wire•Mar 10, 2025•Noramco, Halo Pharma
•
Noramco Acquires Cambrex Drug Product Business UnitContract Pharma•Nov 02, 2023•Cambrex, Noramco, Halo Pharma
•
Ampersand Capital Partners to Acquire Vibalogics GmbHAmpersand Capital•May 29, 2019•Vibalogics, Ampersand Capital, Juniper Pharma, Catalent and 5 others
•
Cambrex’s $252 Million Acquisition of Avista Pharma SolutionsGlobal Legal Chronicle•Dec 29, 2018•Avista Pharma, Cambrex, Halo Pharma, Avista
•
•
Cambrex Acquires High Point Facility and Plans to Triple WorkforceCitybizlist•Sep 25, 2018•Cambrex, Halo Pharma
•
•
Are you a Founder ?
FAQs about Halo Pharma
Explore our recently published companies
- Captain - Montreal based, 2021 founded, Unfunded company
- Navigo - Delhi based, 2024 founded, Unfunded company
- Skynext - Mumbai based, 2020 founded, Unfunded company
- Digital Maker - Peterhead based, 2017 founded, Unfunded company
- Byteport - San Francisco based, 1999 founded, Seed company
- Back Benchers - India based, 2024 founded, Unfunded company